Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06236243 · ClinicalTrials.gov registry record · NA
Effect of Korean Red Ginseng Extract on Blood Flow in Healthy Adults
A NA study of Cardiovascular Diseases and Vasodilation, sponsored by Korea Ginseng Corporation.
- Completed
- Registry status
- NA
- Development phase
- 108
- Enrollment target
- 1
- Study location
NCT06236243 is a NA study of Cardiovascular Diseases and Vasodilation that has completed, run by Korea Ginseng Corporation. The registered enrollment target is 108 participants, below the 26,974-participant average among 300 other Cardiovascular Diseases trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state.
The verdict
NCT06236243, a NA study of Cardiovascular Diseases and Vasodilation, has completed, sponsored by Korea Ginseng Corporation.
- COMPLETED
- Registry status
- NA
- Development phase
- 108 participants
- Enrollment target
- 1
- Study location
Study Summary
The objectives of this clinical trial are to 1) determine the effect of the TP compared to placebo on blood flow and platelet aggregation, 2) to determine the effect of the TP on cardiovascular health compared to a placebo and 3) to assess the safety and tolerability of the TP in healthy adults.
Conditions Studied
Interventions
- DIETARY_SUPPLEMENT Placebo
- DIETARY_SUPPLEMENT Korean Red Ginseng Extract Powder 120 mg/tablet
- DIETARY_SUPPLEMENT Korean Red Ginseng Extract Powder 500 mg/tablet
Study Locations (1)
California
- Valiance Clinical Research - Tarzana
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 108 participants |
| Start Date | 2024-01-31 |
| Est. Completion | 2024-09-25 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06236243
The ClinicalTrials.gov registry entry for NCT06236243 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 108 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 26,974-participant average among 300 other Cardiovascular Diseases trials with a reported enrollment target (100% lower). The listed sponsor is Korea Ginseng Corporation, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 4 conditions, with Cardiovascular Diseases appearing as the primary indexed condition, and to 3 interventions - of which Placebo is the first listed.
NCT06236243 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT06236243 about?
NCT06236243 is a clinical study titled "Effect of Korean Red Ginseng Extract on Blood Flow in Healthy Adults". The objectives of this clinical trial are to 1) determine the effect of the TP compared to placebo on blood flow and platelet aggregation, 2) to determine the effect of the TP on cardiovascular health compared to a placebo and 3) to assess the safety and tolerability of the TP in healthy adults.
What is the current status of trial NCT06236243?
This trial is currently completed. It is a NA study. The enrollment target is 108 participants. The study started on 2024-01-31. Estimated completion is 2024-09-25.
What conditions does trial NCT06236243 study?
This clinical trial studies the following conditions: Cardiovascular Diseases, Vasodilation, Blood Pressure Disorders, Platelet Aggregation.
What interventions are being tested in trial NCT06236243?
The interventions under investigation include: Placebo (DIETARY_SUPPLEMENT), Korean Red Ginseng Extract Powder 120 mg/tablet (DIETARY_SUPPLEMENT), Korean Red Ginseng Extract Powder 500 mg/tablet (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT06236243?
This trial is sponsored by Korea Ginseng Corporation, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06236243 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cardiovascular Diseases
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
The Influence of Chardonnay Marc Intake on Gut and Cardiometabolic Health
RECRUITING · NA
-
Identifying Strategies to Reduce Cardiovascular Risk Among Mothers of Young Children
RECRUITING · NA
-
Insomnia Treatment and Cardiometabolic Health in Older Adults With Posttraumatic Stress Disorder
RECRUITING · NA
-
Deep Brain Stimulation Motor Ventral Thalamus (VOP/VIM) for Restoration of Speech and Upper-limb Function in People With Subcortical Stroke
RECRUITING · NA
-
Effects of Whole vs. Nonfat Milk Consumption on Body Composition in Children
RECRUITING · NA
-
MagicTouch for Treatment of In-Stent Restenosis in Coronary Artery Lesions
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.